Paul A Stahler (Paul Stahler)

Publication Activity (10 Years)

Years Active: 2020-2022
Publications (10 Years): 4

Top Topics

Tyrosine Kinase

Emergency Medical

Gene Expression

Top Venues

Clinical transplantation

This page only lists publications with an associated author ORCID identifier.

Publications

Kevin A Reininger, Guillaume Onyeaghala, Teresa Anderson-Haag, David Schladt, Baolin Wu, Weihua Guan, Casey R Dorr, Rory Remmel, Kymberly D Watt, Arthur J Matas, William S Oetting, Paul A Stahler, Ajay K Israni, Pamala A Jacobson
Higher number of tacrolimus dose adjustments in kidney transplant recipients who are extensive and intermediate CYP3A5 metabolizers. Clinical transplantation (2022)
Kevin A Reininger, Guillaume C Onyeaghala, Teresa Anderson-Haag, David P Schladt, Baolin Wu, Weihua Guan, Casey R Dorr, Rory P Remmel, Kymberly D Watt, Arthur J Matas, William S Oetting, Paul A Stahler, Ajay K Israni, Pamala A Jacobson
Higher number of tacrolimus dose adjustments in kidney transplant recipients who are extensive and intermediate CYP3A5 metabolizers. Clinical transplantation (2022)
Kevin A Reininger, Guillaume C Onyeaghala, Teresa Anderson-Haag, David P Schladt, Baolin Wu, Weihua Guan, Casey R Dorr, Rory P Remmel, Kymberly D Watt, Arthur J Matas, William S Oetting, Paul A Stahler, Ajay K Israni, Pamala A Jacobson
Higher number of tacrolimus dose adjustments in kidney transplant recipients who are extensive and intermediate CYP3A5 metabolizers. Clinical transplantation (2022)
Branden M Petrun, Robert Christie, Rachel M Nygaard, Ajay K Israni, Mark J Hill, Chad J Richardson, Paul A Stahler
Graft survival of fourth-time renal transplant recipients is similar to third-time recipients: A SRTR database analysis. Clinical transplantation 34 (7) (2020)